Hyundai and Kia Tell 14 EV Owners to Park Away From Structures

Fourteen EV owners just got the same advice you give a used lawn mower: don't park it near anything you value. Hyundai and Kia have issued a joint recall covering fourteen vehicles built on the E-GMP platform, citing defective SK On battery cells that raise the risk of thermal runaway. Until a fix is engineered, the guidance is park outdoors, away from structures and other vehicles.

Fourteen is not a typo. It is a targeted recall of a specific cell batch, not a fleet-wide event, which is exactly why it deserves a careful read rather than a category-level panic.

Fourteen Vehicles, One Supplier, One Recurring Pattern

The affected units span the Ioniq 5, Ioniq 6, EV6, and EV9, the four passenger EVs sharing the Hyundai-Kia E-GMP architecture. The common factor is not the platform. It is the SK On cell inside it. NHTSA's guidance mirrors the language used in earlier "park outside" advisories: keep the vehicle away from structures and other vehicles until the remedy is available.

The remedy is the part that is not yet available.

SK On is not a new name in this ledger. Hyundai's ICCU saga has already produced a class-action lawsuit alleging that the fix Hyundai promised did not actually close the book for owners who lost use of their cars for weeks at a time. That is a separate defect from this one, the ICCU is the integrated charging control unit, not the cell, but it lands on the same doorstep, and the reputational math compounds. Kia sold roughly 22,000 EV9s in the U.S. in 2024, and owner reports of drive-unit replacements have already surfaced in the enthusiast press. A fourteen-vehicle cell recall on top of that reads less like an isolated incident and more like the third instalment in a series.

For scale, Kia is running a separate "park outside" recall on roughly 462,000 Telluride crossovers over an unrelated front-seat-motor fire risk, and issued similar guidance to ten EV owners last summer. The pattern here is corporate, repeated advisories to park away from the house, even when the underlying defects are mechanically different. That is what erodes trust: not any single recall, but the cadence.

Owners weighing the real safety data on EV fires versus gas cars should hold two things at once. EVs still burn far less often than internal-combustion cars on a per-vehicle basis. And when a specific cell batch is implicated, the manufacturer is obliged to act with exactly this kind of surgical recall.

SK On's Problem Is Hyundai's Problem, and the Timeline Is What Matters

No remedy date has been confirmed. "Park outside" is a placeholder, not a resolution, and every week without a firm fix timeline is a week the E-GMP brand equity absorbs headline damage it did not earn at the platform level. EV9 buyers paid north of $80,000 for a family SUV. The service experience they are being handed, indefinite outdoor parking, no confirmed remedy window, is not the one the sticker implied.

The comparison that matters is chemistry. LFP-based platforms, BYD's Blade cells, GM's Ultium LFP variants, have not triggered equivalent thermal advisories at anything close to this cadence. That is not a Hyundai-Kia indictment; it is a supplier and chemistry observation. NCM cells from a particular vendor, in a particular production window, are the issue. Not electric propulsion. Not the E-GMP skateboard. The manufacturing philosophy gap between LFP and NCM programmes has been visible on the spec sheet for two years; this recall is the field data catching up.

Canadian owners weighing an E-GMP purchase in 2026 have the switching-from-gas field guide and the hidden ownership-cost breakdown to work with. Neither changes because of fourteen recalled units. What changes is the question you ask the dealer: which cell batch, which production month, and what is the remedy timeline in writing.

The Number to Watch Is the Remedy Date

Fourteen vehicles is a small recall. A supplier without a confirmed fix timeline is a large problem. The date to watch is the one Hyundai and Kia have not yet published: when SK On delivers a validated cell remedy and the "park outside" advisory lifts. If that date lands inside sixty days, this is a supplier stumble that the E-GMP programme absorbs. If it drifts into Q4, the story stops being about fourteen cars.